Compare HII & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HII | TECH |
|---|---|---|
| Founded | 1886 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.1B |
| IPO Year | N/A | 1989 |
| Metric | HII | TECH |
|---|---|---|
| Price | $316.02 | $63.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $320.60 | $71.23 |
| AVG Volume (30 Days) | 407.4K | ★ 1.8M |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.75% | 0.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 14.50 | 0.49 |
| Revenue | ★ $12,012,000,000.00 | $1,216,732,000.00 |
| Revenue This Year | $5.67 | $2.33 |
| Revenue Next Year | $5.24 | $7.05 |
| P/E Ratio | ★ $21.79 | $130.19 |
| Revenue Growth | 2.60 | ★ 3.85 |
| 52 Week Low | $158.88 | $46.01 |
| 52 Week High | $330.00 | $79.28 |
| Indicator | HII | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 58.17 | 55.99 |
| Support Level | $304.01 | $62.84 |
| Resistance Level | $317.78 | $64.73 |
| Average True Range (ATR) | 8.31 | 1.95 |
| MACD | -0.84 | 0.26 |
| Stochastic Oscillator | 83.19 | 69.20 |
Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.